Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 12,984 shares at $49.55 ($643K) on 2023-02-27, disclosed to the SEC on 2023-02-28.
Scheduled sale ($643k) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.55 | 2,984 | $148K | 23.0% |
| 2 | $49.55 | 2,984 | $148K | 23.0% |
| 3 | $49.55 | 7,016 | $348K | 54.0% |
| Total | $49.55 avg | 12,984 | $643K | 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |